point with our research where we know how to save the nerve cells," Dr. Höllerhage notes. In the long term, the neurologists then want to test therapy options in clinical trials to treat patients in the P

directly into the target cell in the lung affected by the virus have already been developed. "The long-term goal is, on the one hand, to use our iGUARD platform to construct corresponding therapeutics for other

deliver the therapeutic RNA directly to the target cell in the lungs affected by the virus. "The long-term goal is to use our iGUARD platform to construct corresponding therapeutics for other known viral diseases

step-by-step through the phases of rehabilitative care - from the time immediately after surgery to long-term care - and presents treatment techniques. Within each phase, users will find nine subcategories on

infection with SARS-CoV-2," adds Dr. Hümmert. No deterioration compared to the time before Corona In terms of quality of life, more than half of the patients surveyed reported mild to extreme problems in the

system is not optimal. "In addition, there is a risk that the insufficiency will return in the long term," reports private lecturer Dr Fabio Ius from the Clinic for Cardiac, Thoracic, Transplantation and

Toronto, Canada and other researchers has led to the development of a new LFS classification under the term "Li-Fraumeni spectrum" that comprehensively reflects the disease severity and facilitates the search

observation and that the therapy will help to improve the quality of life of many patients in the long term in the future. Author: Kirsten Pötzke

and more immunosuppressive treatments, which favors brain infection by the virus. And in the long term, the neurologist is convinced, the therapy principle could also be extended to other neurological

Foundation (DFG) therefore ranks MHH third among all university medical institutions in Germany in terms of third-party funding per professorship. "Last year, we were again able to score with our research